However, one animal study has shown that specific pyrophosphate inhibitors, such as Vx765, act as molecular blockers for NLRP3 inflammasome, thereby offering potential therapeutic value for ischemic stroke recovery and rehabilitation [92]. This evidence concerns the gene NLRP3 and ischemic stroke.